about/contact | site map | advertising


CMS schedules amyloid PET review
Article Thumbnail ImageAugust 28, 2012 -- The U.S. Centers for Medicare and Medicaid Services (CMS) has scheduled a meeting for January 30, 2013, to review evidence on the use of beta-amyloid PET imaging for managing dementia and neurodegenerative disease.

To view the remainder of this article, and other exclusive content, you must first sign-in or register using the options below.
(Helptag:PaywallArticleLoginMessage)
Member Sign In:
  MemberID or E-mail Address:
  Password:
(?)
Forgot your password? Click here.

View our privacy policy
New AuntMinnie.com Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • OnLine CMe/CE
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
    		•

    Specifically, CMS is interested in public testimony on the clinical impact on health outcomes experienced by patients who are afflicted with neurodegenerative diseases, such as Alzheimer's. Medicare currently does not reimburse for beta-amyloid PET imaging.

    Certain PET tracers can image beta-amyloid plaque in the brain, which has been linked to cognitive impairment and decline.

    || About || Advertising || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2013 || Education || Equipment Classifieds || Facebook || Forums || Home || Links || Marketplace || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2012 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2013 AuntMinnie.com. All Rights Reserved.